Liming Sheng

1.1k total citations
44 papers, 784 citations indexed

About

Liming Sheng is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Liming Sheng has authored 44 papers receiving a total of 784 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 23 papers in Oncology and 13 papers in Surgery. Recurrent topics in Liming Sheng's work include Lung Cancer Diagnosis and Treatment (11 papers), Lung Cancer Treatments and Mutations (11 papers) and Esophageal Cancer Research and Treatment (9 papers). Liming Sheng is often cited by papers focused on Lung Cancer Diagnosis and Treatment (11 papers), Lung Cancer Treatments and Mutations (11 papers) and Esophageal Cancer Research and Treatment (9 papers). Liming Sheng collaborates with scholars based in China, Sweden and Germany. Liming Sheng's co-authors include Dan Su, Qichun Wei, Xianghui Du, Xiaojiang Sun, Yongling Ji, Yongjie Shui, Hans Nordgren, Jörgen Carlsson, Guoqin Qiu and Lizhen Zhang and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Cancer and World Journal of Gastroenterology.

In The Last Decade

Liming Sheng

42 papers receiving 771 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liming Sheng China 15 480 273 191 165 146 44 784
Daniel Buergy Germany 13 289 0.6× 152 0.6× 101 0.5× 157 1.0× 143 1.0× 29 674
Daiki Masuya Japan 16 512 1.1× 358 1.3× 158 0.8× 412 2.5× 159 1.1× 49 1.0k
Roberto Díaz United States 19 353 0.7× 321 1.2× 292 1.5× 217 1.3× 113 0.8× 57 1.0k
Teodoro Sava Italy 18 502 1.0× 554 2.0× 282 1.5× 292 1.8× 231 1.6× 69 1.1k
Reinhilde Weytjens Belgium 8 337 0.7× 161 0.6× 69 0.4× 254 1.5× 143 1.0× 18 719
Xiwen Bi China 14 392 0.8× 128 0.5× 64 0.3× 103 0.6× 117 0.8× 46 725
Michiyo Miyawaki Japan 15 263 0.5× 400 1.5× 139 0.7× 107 0.6× 92 0.6× 57 743
Haiyan Wang China 14 227 0.5× 320 1.2× 85 0.4× 159 1.0× 49 0.3× 54 939
Florian Kocher Austria 18 498 1.0× 357 1.3× 130 0.7× 215 1.3× 160 1.1× 72 990

Countries citing papers authored by Liming Sheng

Since Specialization
Citations

This map shows the geographic impact of Liming Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liming Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liming Sheng more than expected).

Fields of papers citing papers by Liming Sheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liming Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liming Sheng. The network helps show where Liming Sheng may publish in the future.

Co-authorship network of co-authors of Liming Sheng

This figure shows the co-authorship network connecting the top 25 collaborators of Liming Sheng. A scholar is included among the top collaborators of Liming Sheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liming Sheng. Liming Sheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sheng, Liming, Jing Yang, Danhong Zhang, et al.. (2023). Radiation pneumonia predictive model for radiotherapy in esophageal carcinoma patients. BMC Cancer. 23(1). 988–988. 7 indexed citations
2.
Zeng, Jing, et al.. (2021). Liposome-paclitaxel and carboplatin combination chemoradiotherapy for patients with locally advanced esophageal squamous cell carcinoma. Cancer/Radiothérapie. 25(5). 441–446. 3 indexed citations
3.
Chen, Guofu, Liming Sheng, & Xianghui Du. (2018). Efficacy and safety of liposome-paclitaxel and carboplatin based concurrent chemoradiotherapy for locally advanced lung squamous cell carcinoma. Cancer Chemotherapy and Pharmacology. 82(3). 505–510. 14 indexed citations
4.
Yang, Yang, Danhong Zhang, Xia Zhou, et al.. (2017). Prophylactic cranial irradiation in resected small cell lung cancer: A systematic review with meta-analysis. Journal of Cancer. 9(2). 433–439. 42 indexed citations
6.
Ji, Yongling, et al.. (2016). A phase I dose escalation study of S-1 with concurrent radiotherapy in elderly patients with esophageal cancer. Journal of Thoracic Disease. 8(3). 451–458. 11 indexed citations
7.
Qiu, Guoqin, Xianghui Du, Liming Sheng, et al.. (2016). Differences in displacement of the proximal and distal ends of mid-upper thoracic esophageal squamous cell carcinoma. Molecular and Clinical Oncology. 5(1). 143–147. 1 indexed citations
8.
Ji, Yongling, Liming Sheng, Xianghui Du, Guoqin Qiu, & Dan Su. (2014). Elevated platelet count is a strong predictor of poor prognosis in stage I non-small cell lung cancer patients. Platelets. 26(2). 138–142. 44 indexed citations
9.
Feng, Xinglai & Liming Sheng. (2013). Gastric adenocarcinoma with thyroid metastasis: A case study and literature review. Oncology Letters. 5(5). 1653–1655. 7 indexed citations
10.
Sheng, Liming, Min Luo, Xiaojiang Sun, et al.. (2013). Serum fibrinogen is an independent prognostic factor in operable nonsmall cell lung cancer. International Journal of Cancer. 133(11). n/a–n/a. 94 indexed citations
11.
Xu, Yaping, Liming Sheng, & Weimin Mao. (2012). Role of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of esophageal carcinoma and the suggested mechanisms of action. Oncology Letters. 5(1). 19–24. 6 indexed citations
12.
Lü, Ke, Xinglai Feng, Qinghua Deng, et al.. (2012). Prognostic Role of Serum Cytokines in Patients with Nasopharyngeal Carcinoma. Onkologie. 35(9). 7–7. 11 indexed citations
13.
Ke, Lu, Yuan Zhu, Liming Sheng, et al.. (2011). Serum Fibrinogen Level Predicts the Therapeutic Response and Prognosis in Patients with Locally Advanced Rectal Cancer. Hepatogastroenterology. 58(110-111). 1507–10. 33 indexed citations
14.
Sheng, Liming, et al.. (2011). Human epidermal growth factor receptor-2 and topoisomerase II alpha expressions in rectal cancer.. PubMed. 58(106). 359–63. 2 indexed citations
15.
Deng, Qinghua, Liming Sheng, Dan Su, et al.. (2010). Genetic polymorphisms in ATM, ERCC1, APE1 and iASPP genes and lung cancer risk in a population of southeast China. Medical Oncology. 28(3). 667–672. 41 indexed citations
16.
Sheng, Liming, Lizhen Zhang, Haimiao Xu, & Yuan Zhu. (2008). Ascending colon adenocarcinoma with tonsillar metastasis: A case report and review of the literature. World Journal of Gastroenterology. 14(46). 7138–7138. 15 indexed citations
17.
Wei, Qichun, et al.. (2008). EGFR, HER2, and HER3 Expression in Laryngeal Primary Tumors and Corresponding Metastases. Annals of Surgical Oncology. 15(4). 1193–1201. 53 indexed citations
19.
Shen, Li, Yongjie Shui, Xiaojia Wang, et al.. (2008). EGFR and HER2 expression in primary cervical cancers and corresponding lymph node metastases: Implications for targeted radiotherapy. BMC Cancer. 8(1). 232–232. 30 indexed citations
20.
Wei, Qichun, Lirong Chen, Liming Sheng, et al.. (2007). EGFR, HER2 and HER3 expression in esophageal primary tumours and corresponding metastases. International Journal of Oncology. 31(3). 493–9. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026